Bioseeker, Feb 2012 AnalyticalTool - CancerTherapeuticAntibodies "AnalyticalTool - CancerTherapeuticAntibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged
Bioseeker, June 2006 AnalyticalTool - The Commercial Success of CancerTherapeuticAntibodies "AnalyticalTool - The Commercial Success of CancerTherapeuticAntibodies" offers a unique tool for analyzing the vast
Bioseeker, Sep 2011, Pages: 3516
publication:
Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development
Bioseeker, Sep 2011, Pages: 3926
Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development strategies for 531 antibody
Bioseeker, Sep 2011, Pages: 4180
Tool for Optimizing the Pipeline from Research To Market
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development strategies for 531 antibody drugs
Bioseeker, Sep 2011, Pages: 3441
Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development strategies for 531 antibody
Bioseeker, Sep 2011, Pages: 3659
publication:
Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development
Bioseeker, Sep 2011, Pages: 3695
Triple Analysis: Breast Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound
Bioseeker, Sep 2011, Pages: 3913
Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development
Bioseeker, Sep 2011, Pages: 4105
Triple Analysis: Lung Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy
Bioseeker, Sep 2011, Pages: 4323
:
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development strategies
Bioseeker, March 2012, Pages: 3706
publication:
Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development
Bioseeker, Sep 2011, Pages: 3838
Triple Analysis: Colorectal Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound
Bioseeker, March 2012, Pages: 4370
Triple Analysis: Lung Cancer, Pancreatic Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Pancreatic Cancer and by the compound
Bioseeker, Sep 2011, Pages: 4709
indications.
This part is based on the following publication:
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Part III: Antibodies
The cancerantibody drug report part comprises defined
Bioseeker, Sep 2011, Pages: 4045
Kinase Therapeutics in Oncology - Where to Commercialize?
Part III: Antibodies
The cancerantibody drug report part comprises defined and up to date development strategies for 531 antibody drugs
Bioseeker, March 2012, Pages: 3885
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the compound
Bioseeker, March 2012, Pages: 4103
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer
Bioseeker, Sep 2011, Pages: 4224
indications.
This part is based on the following publication:
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Part III: Antibodies
The cancerantibody drug report part comprises defined
Bioseeker, Sep 2011, Pages: 4442
different cancer indications.
This part is based on the following publication:
Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Part III: Antibodies
The cancerantibody drug report part